FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against ...

Norovirus levels are increasing across California, and the rise is especially notable in the San Francisco Bay Area and L.A., ...

The pivotal phase 3 RINGSIDE trial investigated varegacestat, an oral gamma secretase inhibitor, in patients with progressing desmoid tumors.

A norovirus outbreak will keep a Medford, Massachusetts, elementary school closed for a second day on Friday, the city's school district announced.

Preliminary Activity Analysis In the 15 efficacy-evaluable patients in the 120 mg cohort, the majority of which received an effective dose of 80 mg QD, enozertinib demonstrated strong systemic and CNS ...

Highly differentiated 1L EGFR PACC preliminary systemic activity of 80% ORR and 100% intracranial ORR, including in patients with active brain ...

Highly differentiated 1L preliminary systemic activity of 67% ORR and 100% intracranial ORR (by BICR-RANO), including in patients with active ...

Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor ...

Ringside’s phase 3 findings reveal the potential varegacestat has to deliver “best-in-class results in a convenient, ...

The United Kingdom activated emergency protocols after the temporary closure of several schools due to an unusual outbreak of ...

Some patients dropped out of the trial early because they had lost so much weight.